Tacrolimus decreases proteinuria in patients with refractory IgA nephropathy

In clinical practice, some IgA nephropathy (IgAN) patients show resistance to or are unable to achieve complete remission using steroids and/or immunosuppressants. The current study aimed to assess the efficacy and safety of tacrolimus in the treatment of cases of refractory IgAN. In this retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Tingyang, Liu, Qingquan, Xu, Qing, Liu, Hui, Qiu, Wenhui, Huang, Fei, Zhang, Shijie, Lv, Yongman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392720/
https://www.ncbi.nlm.nih.gov/pubmed/29718866
http://dx.doi.org/10.1097/MD.0000000000010610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392720/
https://www.ncbi.nlm.nih.gov/pubmed/29718866
http://dx.doi.org/10.1097/MD.0000000000010610

Ejemplares similares